๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Malaria Infection

Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge NCT02639299n/a1 site๐Ÿ“ Bethesda National Institute of Allergy and Infectious Diseases (NIAIโ€ฆ Mass Vaccine and Drug Administration, Bangladesh NCT06068530Phase 42 sites๐Ÿ“ Bฤndarban๐Ÿ“ Lฤma University of Oxford ยท Tests: DHA/piperaquine and a SLD-PQ, Study vaccine R21/Matrix-Mโ„ข ACT vs CQ With Tafenoquine for P. Vivax Mono-infection NCT05788094Phase 41 site๐Ÿ“ Mae Sot Shoklo Malaria Research Unit ยท Tests: Dihydroartemisinin-piperaquine plus tafenoquine (450 mg adult dose), Chloroquine plus Tafenoquine (450 mg adult dose), โ€ฆ Platelet-Directed Whole Blood Transfusion Strategy for Malaria NCT05711485NA2 sites๐Ÿ“ Baltimore๐Ÿ“ Ndola Johns Hopkins Bloomberg School of Public Health ยท Tests: Whole blood transfusion Safety, Tolerability, Pharmacokinetics, and Mosquitocidal Activity of Lotilaner in Healthy Participants in Mali. NCT07758985Phase 11 site๐Ÿ“ Bamako Medicines for Malaria Venture ยท Tests: Cohort 1 low dose lotilaner with a high-fat meal, Cohort 1 low dose placebo with a high-fat meal, Cohort 2 high dose loโ€ฆ Southeast Asia Dose Optimization of Tafenoquine NCT04704999Phase 46 sites๐Ÿ“ Siem Reap๐Ÿ“ Jayapura๐Ÿ“ Vientiane University of Oxford ยท Tests: Tafenoquine, Chloroquine, Artemether 20 mg-Lumefantrine 120 mg, Primaquine, Dihydroartemisinin 40 mg-Piperaquine 320 mg Physiology and Pathologies Linked to Human Splenic Function : Direct and Ex-vivo Perfusion Explorations NCT06418256n/a5 sites๐Ÿ“ Clichy๐Ÿ“ Paris๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris ยท Tests: Spleen, blood and plasma collection PDMC Implementation Trial in Kenya NCT06624631Phase 41 site๐Ÿ“ Kisumu Liverpool School of Tropical Medicine ยท Tests: SMS reminders; adherence support strategy a, Community Health Promoters (CHP) home visits; adherence support strategy bโ€ฆ Focal Mass Drug Administration for the Prevention of Malaria in Pregnancy NCT07021430EARLY Phase 11 site๐Ÿ“ Kasese University of North Carolina, Chapel Hill ยท Tests: Dihydroartemisinin Piperaquine Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar NCT06923592Phase 32 sites๐Ÿ“ Addis Ababa๐Ÿ“ Antananarivo London School of Hygiene and Tropical Medicine ยท Tests: PvSeroTAT, Control Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2) NCT07811908Phase 213 sites๐Ÿ“ Banfora๐Ÿ“ Nanoro๐Ÿ“ Abidjan Novartis Pharmaceuticals ยท Tests: KAE609, SoC (Coartem), KLU156 Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali NCT01168271n/a2 sites๐Ÿ“ Bamako๐Ÿ“ Wolossรฉbougou National Institute of Allergy and Infectious Diseases (NIAIโ€ฆ Assessing Vaccine Effectiveness of R21/Matrix-M Across Malaria Transmission Settings (AVERT) NCT07749911n/a21 sites๐Ÿ“ Boromo๐Ÿ“ Boromo๐Ÿ“ Houndรฉ Clinton Health Access Initiative Inc. ยท Tests: R21/Matris-M Malaria vaccine A Controlled Human Vivax Malaria Infection Study Through Inoculation of Infected Erythrocytes NCT05071079NA1 site๐Ÿ“ Bangkok University of Oxford ยท Tests: An inoculum of malaria parasitised red blood cells with whole dose blood-stage inoculum, An inoculum of malaria parasitโ€ฆ Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-typhoidal Salmonella Disease NCT07416461n/a1 site๐Ÿ“ Kinshasa International Vaccine Institute ยท Tests: R21/Matrix-M malaria vaccine Clinical Aspects, Management and Surveillance of Febrile Illnesses in DRC NCT07345286n/a1 site๐Ÿ“ Kinshasa Institute of Tropical Medicine, Belgium Post-discharge Malaria Chemoprevention Implementation Trial in Benin NCT06601712Phase 42 sites๐Ÿ“ Abomey๐Ÿ“ Cotonou Institut de Recherche Clinique du Benin ยท Tests: Adherence support strategy A, Adherence support strategy B, Control Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants NCT05285735n/a1 site๐Ÿ“ Piscataway Amivas Inc. A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months NCT07036159Phase 22 sites๐Ÿ“ Kigali๐Ÿ“ Kigali GlaxoSmithKline ยท Tests: RTS,S/AS01E vaccine An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older NCT06666491Phase 35 sites๐Ÿ“ Ahmedabad๐Ÿ“ Bikaner๐Ÿ“ Kolkata GlaxoSmithKline ยท Tests: Tafenoquine, Primaquine, Chloroquine Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases. NCT07468513Phase 44 sites๐Ÿ“ Manaus๐Ÿ“ Arba Minch๐Ÿ“ Alexishafen Menzies School of Health Research ยท Tests: Patients with G6PD enzyme activities between 30 and <70% of the AMM will be treated with schizontocidal treatment plโ€ฆ Integrating Malaria Vaccine With Seasonal Malaria Chemoprevention in West Africa NCT06860178Phase 42 sites๐Ÿ“ Ouagadougou๐Ÿ“ Bamako Epicentre ยท Tests: Annual campaign of the 3-dose primary series vaccine R21/Matrix-M aligned with SMC distribution in children aged 3-59 mโ€ฆ Clinical Study to Assess Minimum Mosquito Bites for P. Vivax Infection in Thai Adults NCT07257965NA1 site๐Ÿ“ Bangkok University of Oxford ยท Tests: Mosquito bite (1 or 2 or 3) An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine NCT07009847n/a5 sites๐Ÿ“ Bousse๐Ÿ“ Toumodi๐Ÿ“ Yenagoa Serum Institute of India Pvt. Ltd. ยท Tests: Case control study of clinical malaria, Case control study of severe malaria, Case control study of death (all cause) L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) NCT05934318NA1 site๐Ÿ“ Kisumu Liverpool School of Tropical Medicine ยท Tests: L-citrulline Evaluation of Artesunate in Infants Being Treated for Severe Malaria NCT06555809n/a1 site๐Ÿ“ Paris Amivas Inc. ยท Tests: Artesunate Injection Safety and Efficacy of Imatinib in Combination With Artemether-Lumefantrine for Uncomplicated Malaria NCT07559370Phase 21 site๐Ÿ“ Kisumu Victoria Biomedical Research Institute ยท Tests: Artemether lumefantrine tablets, Artemether Lumefantrine and Imatinib Mesylate Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective NCT07358910n/a1 site๐Ÿ“ Phnom Penh Institut Pasteur du Cambodge Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine NCT05041556n/a4 sites๐Ÿ“ Kintampo๐Ÿ“ Nairobi๐Ÿ“ Nairobi Kintampo Health Research Centre, Ghana ยท Tests: Case-control study of clinical outcomes, Case-control study of mortality outcome Surveillance of AMR in DRC NCT06821282n/a1 site๐Ÿ“ Kinshasa University of Oxford
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy